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Abstract Seizures are a frequent complication of brain injury,
including intracerebral hemorrhage (ICH), where seizures
occur in about a third of patients. Rodents are used to study
pathophysiology and neuroprotective therapies after ICH, but
there have been no studies assessing the occurrence of sei-
zures in these models. Thus, we compared seizure incidence
and characteristics after infusing collagenase (0.14 U), which
degrades blood vessels, and autologous blood (100 μL) into
the striatum of rats. Saline was infused in others as a negative
control, whereas iron, a by-product of degrading erythrocytes,
served as a positive control. Ipsilateral and contralateral elec-
troencephalographic (EEG) activity was continuously moni-
tored with telemetry probes for a week after the stroke. There
were no electrographic abnormalities during baseline record-
ings. As expected, saline did not elicit any epileptiform activ-
ity whereas iron caused seizure activity. Seizures occurred in
66 % of the collagenase group between 10 and 36 h, their
duration ranged from 5 to 90 s, and these events were mostly
observed bilaterally. No such activity occurred after blood
infusion despite comparable lesion sizes of 32.5 and
40.9 mm3 in the collagenase and blood models, respectively
(p=0.222). Therefore, seizures are a common acute occur-
rence in the collagenase but not whole blood models of striatal
ICH (p=0.028, for incidence). These findings have potential
implications for ICH studies such as for understanding model
differences, helping select which model to use, and determin-
ing how seizures may affect or be affected by treatments
applied after stroke.
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Introduction
Intracerebral hemorrhage (ICH) occurs in ~15 % of stroke
patients, leading to ~50 % mortality and significant disability
in survivors [1, 2]. So far, there are no specific neuroprotective
therapies for ICH, although survivors benefit from rehabilita-
tion. Thus, it is important to fully understand those factors that
affect outcome after ICH in order to improve medical manage-
ment and further limit death and disability. For instance, sei-
zures are a common occurrence after ICH or even a presenting
sign of an ICH. About 4–20 % of ICH patients will suffer from
clinical seizures (e.g., convulsions), whereas 30 % of ICH
victims will have subclinical seizures observable on an elec-
troencephalogram (EEG; [2–4]). Current data suggests that the
risk of seizures occurring within the first month is 8 % [3], and
the risk of a seizure occurring after the first month and within
the first year is 3 % [4]. Still, this could be an underestimate
caused by the lack of continuous EEG monitoring in patients.
Intuitively, seizures are expected to worsen outcome after
an ICH. Seizures can exacerbate excitotoxicity and oxidative
stress [5, 6], augment metabolic rate [7], and cause re-bleeding
or increased bleeding due to elevated blood pressure and
blood flow during seizures [3, 8, 7]. Intracranial pressure
(ICP) also rises due to seizures [9], which can cause compli-
cations after ICH (e.g., herniation) and increase mortality [2].
Seizures may also cause aberrant brain plasticity (e.g., larger
cortical maps) and impair recovery [10]. Lastly, even though
the number of ICH patients that develop epilepsy is relatively
low (2–5%), the incidence of one seizure increases the chance
of developing epilepsy [2, 4, 3].
All of this illustrates why seizures could be harmful. Clin-
ical studies on this topic, however, have not consistently found
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that seizures are detrimental [11, 2–4], although some support
this notion [12–14]. This variability among clinical studies
could be attributed to several factors, such as inclusion criteria,
methods for measuring EEG, lack of continuous EEG moni-
toring, use of anti-epileptic drugs (AEDs), among others.
Current guidelines suggest that ICH patients with a depressed
mental state should have continuous EEGmonitoring, as most
seizure activity occurring after ICH is subclinical [2–4, 15].
Any seizure activity ought to be treated intravenously with an
AED, and if seizure activity persists, AED treatment may
continue orally. Prophylactic administration of AEDs, how-
ever, has been discouraged after evidence from studies indi-
cating a worsening of outcome caused by administration of
phenytoin before any signs of seizure activity after not only
ICH [15, 16] but also traumatic brain injury [17].
The incidence and consequences of seizures after an ICH
have not been well studied in animal models. Thus far, swine
studies have shown that excitability increases in certain areas
of the brain after ICH [18]. Others have shown that in rodents,
the most widely used ICH model, intracerebral infusions of
blood components such as thrombin [19] and iron [20] cause
seizures. To our knowledge, there have been no formal eval-
uations of seizure activity in the common rodent models of
ICH, which involve injecting autologous blood [21] or colla-
genase [22] into the brain. Unlike the whole blood injection,
bacterial collagenase, an enzyme that breaks down the basal
lamina, causes bleeding over hours mimicking what frequent-
ly occurs in ICH patients [22, 23]. Often, investigators target
the striatum as it is a common site of ICH in humans and
because it can contain a large hematoma that results in persis-
tent, easily quantified, behavioral impairments [24]. In this
study, we induced a moderate-sized striatal ICH in rats by
injecting collagenase or whole blood, and we monitored rats
with an implanted EEG telemetry probe for a week after the
stroke. By using telemetry, we were able to continuously
record EEG in freely moving untethered animals, which is
the least stressful method for these animals. The objective of
this study was to determine the incidence and characteristics
of seizures that occur in these animal models of ICH.
Methods
Subjects
Twenty male Sprague-Dawley rats (250–400 g, ~3 months
old) obtained from the Biosciences breeding colony at the
University of Alberta were assigned to either the collagenase,
whole blood, or saline group. As a positive control, a rat
received an injection of FeCl2. Food (Purina rodent chow)
and water were provided ad lib and rats were housed individ-
ually in a temperature- and humidity-controlled room (lights
on from 7 a.m.–7 p.m.).
EEG Probe Implantation
Surgical procedures were performed aseptically. Rats were
anesthetized with isoflurane (4 % induction, 1.5–2.5 % main-
tenance in 60 % N2O, balance O2) and body temperature was
maintained at 37 °C during anesthesia with a heated water
blanket and a rectal temperature probe. An EEG telemetry
probe (F40EET, Data Sciences International, St. Paul, MN)
was inserted either in the peritoneal cavity or the neck (dorsal
S.C. placement), and the leads were channeled under the skin
and attached to screws stereotaxically placed ipsilateral (AP
−1.5, ML 4) and contralateral (AP −1.5, ML −4) to the
injection site (see Fig. 1). The leads were secured to the screws
(0–80×3–32; Plastics One, Roanoke, VA) with dental cement.
These telemetry probes measure EEG (sampled at 500 Hz,
low-pass filtered at 100 Hz) and temperature and movement
activity. The latter is detected by changes in signal strength as
the probe moves across the receiver (Data Sciences Interna-
tional), providing a relative measure of activity [25].
Iron Injection
As a positive control to assess the ability of the EEG probe to
detect seizures, we injected iron in the rat striatum (N=1).
Immediately following attachment of the electrical leads, a
hole was drilled (AP 0.5, ML 3.5) and a Hamilton 26-gauge
needle was inserted 6.5 mm into the striatum to infuse 38.0 μg
of FeCl2 in 30 μL of saline [26, 27]. The injection was
completed over 10 min and the needle was removed after an
additional 10min. Clips were used to close the wound. The rat
was euthanized 1 week later.
Collagenase, Blood, and Saline Injections
For the saline (N=3) and five of the collagenase rats (N=10), a
baseline recording period of 1 week was undertaken before
the injection. No baseline recording was done for the whole
blood rats (N=6). Following baseline recordings, or directly
after the securing of electrical leads, a hole was drilled (AP
Fig. 1 Telemetry probe inserted either in the peritoneum or under the
skin of the neck (left). Leads were attached to screws (striped circle) on
the skull and cemented. One channel recorded from the ipsilateral hemi-
sphere next to the site of injection (full circle) and the other channel
recorded from the contralateral side. Negative leads were connected to a
screw posterior to Lambda. No further grounding was required
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0.5, ML 3.5) and a Hamilton 26-gauge needle was inserted
6.5 mm into the striatum. Either saline, 100 μL of autologous
whole blood (from tail artery), or 0.14 U of bacterial collage-
nase in 0.7 μL of sterile saline was infused over 5 or 10 min
(blood model) and the needle was removed after an additional
5 or 10 min [23]. Clips were used to close the wound. Saline
control and whole blood rats were euthanized after 7 days
whereas the collagenase rats were euthanized between 11 and
66 days. This difference in survival times was due to differ-
ences in probe placement and technical difficulties that en-
sued. For instance, probe placements in the neck region
caused irritation due to collection of fluid (seroma).
Euthanasia and Lesion Volume Assessment
Rats were injected with sodium pentobarbital (100 mg/kg,
i.p.) and then perfused with 0.9 % saline followed by 10 %
neutral buffered formalin. Brains were extracted, cryostat-
sectioned at 40 μm, and stained with cresyl violet. Coronal
sections taken every 200 μmwere then analyzed with Image J
[28], as routinely done on digitized images extending anterior,
through, and posterior to the lesion. The volume of each
hemisphere was calculated as follows: (average area of com-
plete coronal section of the hemisphere−area of damage−
ventricle)×interval between sections×number of sections
[26, 23]. This method takes into account both areas of injury
as well as atrophy and ventricular dilation.
EEG Analysis
Baseline and post-infusion EEG traces were visualized with
Dataquest A.R.T. 2.3 system (Data Sciences International) and
the incidence, duration of seizures, as well as the time to
seizure onset from injection were recorded. In three rats, an
extended period of 30 days was further analyzed in this way.
We compared 5-min epochs of non-epileptiform activity from
the day prior to the injection with recordings taken at least
3 days post-stroke from the rats that had a 1-week baseline
recording (collagenase N=4; saline N=3) in order to detect
any changes in otherwise normal-looking EEG. We did not
find a significant difference between the day prior to collage-
nase infusion and day 3 after stroke. Therefore, we considered
traces from the third day post-collagenase infusion to be an
additional substitute baseline measure for all collagenase rats.
Baseline and putative epileptiform traces were exported and
analyzed using custom code written in MATLAB (R2012a,
Mathworks, Natick, MA). We computed for each signal the
root mean square (RMS), the power spectral density using
Welch’s averaged modified periodogrammethod (6-s window,
2-s overlap), as well as dual channel coherence for ipsilateral
and contralateral recordings (3-s window; 1-s overlap). Field
signals and spectra were plotted for comparison with baseline
measures using Origin 9.1 (Microcal Software, Northampton,
MA).We compared all putative epileptiformmeasures, includ-
ing RMS and 95 % confidence intervals of amplitude fluctu-
ations, to those taken during baseline/control conditions in
order to confirm that the events were abnormal. For ictal traces
longer than 25 s, power spectra were compared to those
baseline traces equal in duration to determine total increases
in power, frequencies significantly affected by the seizures, as
well as bilateral coherence. A randomized coherence distribu-
tion based on a series of sequential time-shifted (and time-
reversed) coherence computations from these actual traces was
computed to calculate the coherence significance level. The
maximum 95 % confidence limit for this randomized distribu-
tion (throughout the frequency range) across multiple datasets
having durations ranging from 27 to 87 s ranged from 0.22 to
0.061, respectively. In order to determine cross-hemispheric
coupling changes during epileptiform activity, we subtracted
the coherence values of normal activity from those of epileptic
traces and considered that any increases equal to or larger than
the confidence limit for that trace was significant. For shorter
duration aberrant activity (i.e., interictal spikes), we performed
a detection analysis based on a threshold amplitude beyond the
amplitude distribution of the normal traces (3.5 standard devi-
ations from the mean [29] and computed the average wave-
form and number of events occurring per unit time).
Temperature and Activity
We computed temperature averages (F40EET probe) of 5-min
periods taken from the hour after the seizure as the difference
from the hour prior (e.g., 1 h before seizure average−5-min
temperature average) and statistically analyzed it for compari-
son. If a seizure occurred in the hour before another seizure,
then it was excluded. In the samemanner, 1-h activity measures
before and following seizure were averaged and compared to
assess the impact of seizures on activity (as measured by signal
strength changes as the probe moved across the receiver).
Statistical Analysis
Data are presented asmean±standard deviation (SD) and were
analyzed by repeatedmeasures analysis of variance (ANOVA)
and student’s t tests (SPSS v.17.0, SPSS Inc., Chicago, IL).
The Fisher’s exact test and Mann-Whitney U tests were used
to compare between models.
Results
Baseline EEG in the Collagenase Group
Baseline recordings allowed us to relate different behaviors to
the EEG traces (Fig. 2), which were helpful for detecting
abnormal activity. When we compared the RMS of 5-min
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traces of the day prior to stroke/sham surgery and days 1, 2,
and 3 after the injection of either saline or collagenase (in-
cluding only those ICH rats with seizures), we found a group
(saline vs. collagenase) effect for the ipsilateral channel (p=
0.050, Fig. 3) depicting an increase in RMS in non-epileptic
EEG traces after the injection in the collagenase group. This
means that the average amplitude fluctuation of traces was
higher for the collagenase group even during non-epileptic
EEG. Moreover, there was a time effect for the contralateral
side (p=0.028), the RMS on the first day after injection was
larger than the third day (p=0.040) in both groups, although
there was no treatment effect.
Seizures After Collagenase and Iron Injection
One collagenase rat had to be excluded due to equipment
failure that did not allow for adequate EEG recordings. Six
out of the nine remaining rats (66 %) had seizures within the
first 2 days after the stroke with the earliest occurring after
~10 h and the latest occurring after ~36 h. Seizures ranged in
duration from ~5 to 90 s, and their averages ranged from 14 to
54 s (Table 1, Fig. 4b–d). Iron also caused seizures within hours
of application (Fig. 4a), which displayed a similar pattern of
tonic-clonic ictal events followed by notable EEG suppression
and occasional afterdischarges. Seizures or other electrographic
abnormalities were not observed in any of the six rats infused
with 100 μL of autologous blood (p=0.028 for comparing
number of rats with seizures between models). Not surpris-
ingly, both the number (p=0.036) and duration of seizures
(p=0.036) were significantly greater in the collagenase model.
Fig. 3 RMS increased in normal EEG after collagenase-induced ICH in
the ipsilateral side. An overall RMS-fold increase from the day prior to
stroke for a period of 3 days was detected in the collagenase rats that had
seizures (N=4) compared to saline injection in the ipsilateral side (p=
0.05). This indicates that there were more fluctuations in the EEG traces
relating to normal activity after collagenase than after saline (sham sur-
gery) infusion. This was not the case for the contralateral side, for which
there was a day effect for both groups but no impact of the treatment
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Fig. 2 EEG traces during normal behavior. These are examples of EEG
activity during a awake and alert periods, which display higher frequency
and lower amplitude than c slow-wave sleep. During anesthetics, such as
b isoflurane, it is common for EEG to display burst-suppression in rats.
We were also able to detect artifacts such as during d chewing in the EEG
traces. In these instances, the experimenter observed all these behaviors
In two collagenase rats, we detected extended periods of
interictal epileptiform discharges, ranging from ~1.5 to 14 h
(Fig. 5). Over the span of 30min in which seizures occurred in
one animal, we detected abnormal interictal events in between
obvious ictal activity. Interictal activity did not last more than
2 min; therefore, we were not able to analyze them using our
event detection analysis due to their short duration. For the
three rats in which 30 days of EEG were screened, two had
seizures within 36 h, but none of them had any noticeable
EEG abnormalities after that period. Therefore, none of our
collagenase rats appeared to have developed epilepsy per se.
Most of the seizures were bilateral, which were likely gener-
alized from an initiation zone located in the affected hemi-
sphere and propagated across contralateral hemisphere. There
was only one case in which the seizure activity occurred only
ipsilaterally (Table 1).
Severity of Seizures in the Collagenase Group
We calculated RMS and quantified power increases of seizure
traces and compared them to non-epileptic activity taken from
day 3 post-collagenase surgery as an indicator of increases in
amplitude at different frequencies (power) and fluctuations in
the amplitude (RMS) of the ictal events. The smallest RMS-
fold increase for the ipsilateral side was 1.58 times larger than
non-epileptiform activity, and the largest was 4.69 times larger
during ictal activity. Similarly, for the contralateral side, the
smallest epileptiform RMS was 1.45 times larger, and the
largest was 4.96 larger. This indicates that during seizure
activity, there was about a 50–500 % increase in amplitude
fluctuations in these traces. In general, increases in power
were seen at all frequencies up to 38 Hz, with a decrease in
frequencies across the 0.5–5.8 Hz bandwidth detected in a
single rat (Table 1). Also, in most cases, the ipsilateral channel
had an equal or greater increase in power than the contralat-
eral, although this was not the case for two rats. This could
support the notion of an ipsilateral focus that propagates, and/
or generalizes, to the contralateral hemisphere.
For coherence calculations, we concentrated on increases
in coherence at the frequencies in which we noted a change in
power. Coherence values range from 0 to 1; values of 0
indicating that signal-specific frequencies between the two
channels are completely unrelated, whereas values of 1 indi-
cate that they are completely related. In most instances, we
found significant increases in cross-hemispheric coherence
during epileptiform activity as compared to normal traces
taken 3 days after the collagenase injection (average increase
across frequencies 0.28±0.14). Two cases showed exceptions
to this rule, one in which no increase was observed and
another in which coherence values were significantly de-
creased despite prominent bilateral seizure activity in both
cases. In one rat, we also detected that coherence was de-
creased for frequencies lower than 6 Hz but that for higher
frequencies coherence was increased. Indeed, increases in
power for higher frequencies (12–40 Hz) during seizure
events were all associated with significantly increased coher-
ence (see example in Fig. 6). This might indicate that the more
severe seizures were, the more likely that both hemispheres
were engaged in epileptic activity.
Lesion Volume
The infusion of collagenase or blood caused significant dam-
age and inflammation, as depicted in Fig. 7a (p=0.22 for
lesion volume). In the collagenase model, we found no sig-
nificant relationships between lesion volume and seizure
Table 1 Characteristics of seizures after collagenase-induced ICH. EEG
activity occurring in the first week after collagenase injection were
visualized and analyzed. These are the characteristics for the seizures that
occurred within the first 36 h after the stroke; no seizures were detected
afterwards. For each rat, the number of seizures, laterality, total duration,
and time of onset were documented. We also reported other factors to
determine the variability of the traces as depicted by the RMS ratio (RMS
seizure/RMS non-epileptic activity) and changes in voltage according to
their frequency, as depicted by the power increased and frequencies
affected. Also, for those frequencies in which the power was affected,
coherence was assessed as an indicator of how coupled the activity was in
between both channels. Here, coherence was computed as an increase
from baseline coherence. Traces shorter than 25 s were not analyzed for
power and coherence. Data expressed as M±SD







1 1 Ipsilateral 14 11 h, 52 min 2.44 N/A N/A N/A
2 2 Bilateral 102 (51±19.80) 18 h, 50 min 1.9±0.33 ↑ 0–4.6 34.11±14.66 −0.53±0.11





4 4 Bilateral 108 (27±4.9) 16 h, 25 min 2.65±0.23 ↑ 1.07–6.2 16.01±3.99 0.34±0.022
5 8 Bilateral 173 (21.62±17.76) 11 h, 37 min 4.13±0.43 ↑ 0–39.9 71.03±14.57 0.42±0.19
6 14 Bilateral 616 (44±46.24) 9 h, 57 min 2.53±0.53 ↑ 0–47 33.77±16.07 0.24±0.025
aOccurring in frequencies below 5.8 Hz
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incidence (r=0.18, p=0.65; see Fig. 7b), time of onset after
stroke (r=0.30, p=0.56), total (r=0.37, p=0.31) and average
time spent in seizure activity (r=0.18, p=0.63), RMS (r=0.18,
p=0.65), and power increase (r=0.29, p=0.63). Thus, we did
not find that lesion volume predicted seizure characteristics in
this model. Owing to the lack of seizure activity, we did not
perform this analysis with the whole blood model data.
Temperature and Activity Data
A repeated measures ANOVA did not depict a difference
among the twelve 5-min average intervals (i.e., 1 h) following
the seizure (p=0.382), indicating that there were no changes in
temperature after the seizure. Even though there was no
pattern in the temperature change among rats, one rat had a
seizure leading to about 90 min of hypothermia (Fig. 8).
Moreover, a paired t test on all of the rats’ movement activity
indicated no difference between activity before and after the
seizure (p=0.7968).
Discussion
We expected seizures to occur in the blood infusion model,
but this was not observed. Our results did confirm our hy-
pothesis that seizures commonly occur after striatal ICH in the
collagenase model. Sixty-six percent of rats in the collagenase
Fig. 4 Seizures occurring after iron injection and collagenase-induced
ICH. Examples of long-lasting seizures after a iron injection as well as b–
d in three different rats given a striatal collagenase-induced ICH. Onset of
seizures would be delayed by 10 h or more, and they would range
anywhere from 5 to 90 s. Note the characteristic extended periods of
suppression (highlighted in gray and expanded on the bottom panels)
after high frequency and amplitude bursting. The confidence intervals
(95 %) of normal activity 3 days post-stroke are indicated on the right of
the traces
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group suffered seizures during the first 36 h following their
stroke. Seizures commonly occur after brain injury and stroke,
both in patients [30, 2, 31] and in other animal models of brain
injury [32–34]. Thus, it is not surprising that collagenase rats
would also display abnormal electrical activity as we demon-
strated in this study, including both full-blown ictal and ab-
normal interictal activity, which mostly occurred bilaterally.
Increased cross-hemispheric coherence coinciding with in-
creased power suggests that the activity in both hemispheres
during seizure activity was coupled and that more severe
seizures recruited both hemispheres. Although there were
some exceptions to this, coherence remained significantly
increased, especially at the higher frequencies. We also dem-
onstrated that even normal-looking electrical activity has an
increased RMS for the first 3 days after collagenase-induced
ICH, which could indicate that there were abnormalities in
non-epileptic EEG activity during this limited time frame.
Although robust epileptiform activity was a consistent phe-
nomenon in our collagenase group, we did not find lesion
volume to be a predictor for any of the seizure characteristics.
Likewise, the lack of seizures in the blood model, which had a
comparable lesion, argues against lesion or hematoma volume
as key predictors of seizure activity.
The incidence of electrographic seizures in our collagenase
group (66 %) is more than double that documented in ICH
patients [2]. The difference in incidence might be attributed to
the greater range in patient characteristics (e.g., ICH locations,
severity) in clinical studies, along with other factors such as
species differences. Interestingly, other pre-clinical studies of
brain insults, namely, hypoxic-ischemic injury [33], focal is-
chemia [34], and traumatic brain injury [32], all report a much
higher percentage of animals developing seizures and epilepsy
than what is reported in the clinic. However, continuous mon-
itoring of EEG for many weeks or months is rare in clinical
studies, making it difficult to compare animal and clinical data.
There are key differences between the collagenase and
whole blood models that may explain the discrepancy in
seizure incidence between these models. For instance, the
whole blood model of ICH provides a somewhat different
profile of injury (see Fig. 7a) with less secondary injury,
inflammation, blood brain barrier damage, and smaller intra-
cranial pressure spikes [23, 35, 36], but these may vary by
species [37]. As with inflammation [38], it is possible that the
timing, extent, and localization of thrombin production vary
between models and this might account for differences in
seizure activity. Note that intracerebral infusions of thrombin
induce seizure activity [19]. Iron infusions also cause epilep-
togenic activity [20], as we presently confirmed. However,
given the timing of iron release, which in our collagenase
model occurs between 24 and 72 h [39], it is unlikely that
iron causes seizures as they began between 10 and 22 h, and
stopped by 36 h. As well, the hematoma volume is expected to
be larger in rats infused with 100 μL of blood than those given
collagenase [23]. Thus, if iron were the primary cause of
seizures, there should have been more seizures in the whole
blood model.
Early seizures are predictors of future epilepsy in stroke
patients [13], although a study by Bladin and colleagues [4]
Fig. 5 Interictal epileptiform activity in two collagenase rats. In our
study, these rats (a, b) suffered extended periods of aberrant interictal
activity. Note the characteristic downward spiking. For rat A, spikes
occurred about 20 times per minute, and in rat B, they occurred 10 times
per minute. The interictal events elicited over 1 h were averaged, as
depicted at the bottom of the figure. The confidence intervals (95 %) of
normal activity 3 days post-stroke are indicated on the right of the traces
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showed that all of the patients that had late onset seizures,
which were those at 2 or more weeks after the stroke, devel-
oped epilepsy. We did not find recurrent seizures after the first
36 h of the stroke, even though we screened EEG for up to a
month after collagenase infusion. While this suggests that this
model does not lead to epilepsy, a much larger sample size is
needed especially given the small percentage expected to de-
velop that condition. There is also the possibility that seizures
may develop later than a month after ICH in rats, as occurs in
other animal models such as traumatic brain injury [32].
There are some limitations to this study. First, we did not
video record any of the seizure events, so the type of behav-
ioral manifestations with these electrographic seizures remains
unknown. Although, we occasionally noticed behavioral signs
of focal seizures, such as clonic paw movements. Second, the
relatively limited number of animals in this study cannot
exclude the possibility that occasional seizure activity occurs
in the whole blood model. Third, with larger sample sizes, a
modest relationship between lesion volume and seizure
Fig. 6 Seizures displayed higher power and increased coherence than
normal EEG. This is an example of the coherence (top panel) and power
spectrum (bottom panel) for the epileptiform event in Fig. 4d (dashed
line) compared to normal EEG activity 3 days after collagenase-induced
ICH (solid line). Any increase in coherence above the confidence interval
limit (dotted line) of the difference between seizure and normal activity
(gray solid line) was significant. The gray lines in the power spectrum
represent the 95 % confidence interval (CI) and the black lines the mean
values for the spectrum. For those increased frequencies, there were also
increases in coherence
Fig. 7 Lesion volume had no relationship with seizure incidence. The
ICH typically damaged a substantial portion of the striatum with some
damage to corpus callosum. No injury was found in sham-operated rats,
other than a needle track. a Total lesion volume (M±SD in mm3) for the
collagenase and whole blood models was not significantly different.
Photomicrographs illustrate each model’s profile of injury at the level of
maximal damage (cresyl violet stain). b There was no significant corre-
lation between lesion volume (black squares) and the incidence of sei-
zures in the collagenase model (r=0.16, p=0.67)
Fig. 8 Temperature changes (post-seizure minus pre-seizure values) for
2 h post-seizure activity. Values are expressed as difference between
baseline average and temperature (e.g., values below 0 indicate that
hypothermia occurred after the seizure). Time 0 would be the time at
which rats suffered of a seizure. There were no consistent changes in
temperature among the rats
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characteristics may have been detected. Indeed, others have
reported a relationship between epileptiform activity and in-
farct size after focal ischemia [40]. In a clinical study, howev-
er, small lesion size was a better predictor of seizure incidence
[3]. Fourth, while we recommend use of telemetry probes,
tethered systems have the advantage of allowing monitoring
from more locations, which would be advantageous in future
studies (e.g., to identify seizure focus). The use of telemetry
probes also had some additional disadvantages (e.g., greater
cost) including technical problems we encountered with the
use of lead extenders and of course the inevitable loss of
battery power. Lastly, while EEG eventually returned to nor-
mal, it is likely that seizure thresholds were altered as found in
traumatic brain injured rats given a pro-convulsant challenge
[32].
Further studies should be carried out to advance our knowl-
edge of seizures occurring after ICH. Seizure incidence should
be studied after changing the location of the lesion, as lobar/
cortical location has been associated with more seizure activ-
ity in patients [3, 4]. Even though the striatal model of ICH is a
common one, other structures have also been targeted, such as
cortex [18] and hippocampus [41], and we are presently
evaluating these models. It is possible that whole blood injec-
tions in different locations may elicit seizure activity. Also,
patients with an ICH also have increased ICP after the insult
[15], which is also common after a collagenase-induced ICH
in rats [36]. This sustained rise in ICP could be associated
either to the mass effect arising from the hematoma and edema
or to seizure activity, which could especially be related to ICP
spiking [9]. This could be elucidated by simultaneous EEG
and ICP monitoring. Furthermore, future research should
focus on the relationship between seizures, cell death, and
recovery. Some clinical studies have related seizures with
worsened outcome and mortality [12–14], although others
failed to do so [11, 2–4]. In animal models, we can experi-
mentally increase seizure activity with convulsant drugs or
diminish it with AEDs and test its impact on several markers
of cell death (e.g., neurodegeneration) and functional
outcome.
In conclusion, seizures occur in the majority of rats sub-
jected to a collagenase-induced striatal ICH but did not occur
after infusion of whole blood—models widely used to study
the pathophysiology of ICH and to assess neuroprotectants
and rehabilitation therapies [35]. As ICH patients also suffer
from seizures early after the stroke, the rat collagenase model
has good face validity to model seizures occurring after ICH,
although further work is needed to determine whether the
underlying cause is the same as in patients. This is a key factor
for translational purposes, as others have raised concerns
regarding differences between animal and human ICH patho-
physiology [42, 43, 35, 44–46]. Researchers should also con-
sider that seizures could potentially impact their studies. For
instance, seizure activity may exacerbate the damage caused
by the stroke, altering the effectiveness of neuroprotective
therapies. Also, treatments may indirectly reduce cell death
by ameliorating seizure activity. We recommend the use of the
whole blood model when seizures may be a confounding
factor. As this is the first study to find that seizures occur after
collagenase-induced ICH in rats, we encourage further re-
search to understand the relationship between seizures, cell
death, and recovery after ICH. This way, we will be able to
enhance therapies currently provided to ICH patients.
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